|
Q3 2024
|
12 |
2,111,204 |
ARDENT HEALTH PARTNERS INC, ELS, VTI, EQR
|
13F-HR
|
11/14/2024 |
000090514824003129 |
|
Q2 2024
|
10 |
649,240 |
ELS, VTI, EQR, EQC
|
13F-HR
|
8/14/2024 |
000090514824002223 |
|
Q1 2024
|
13 |
922,332 |
ELS, VTI, EQR, EQC
|
13F-HR
|
4/30/2024 |
000090514824001234 |
|
Q4 2023
|
14 |
1,192,553 |
ELS, PARR, VTI, EQR
|
13F-HR
|
2/14/2024 |
000090514824000696 |
|
Q3 2023
|
13 |
1,339,565 |
ELS, EQR, PARR, VTI
|
RESTATEMENT
|
12/4/2023 |
000090514823001550 |
|
Q2 2023
|
20 |
1,480,846 |
ELS, EQR, VTI, PARR
|
13F-HR
|
8/14/2023 |
000090514823000732 |
|
Q1 2023
|
20 |
760,250 |
ELS, PARR, VTI, EQR
|
13F-HR
|
5/15/2023 |
000090514823000436 |
|
Q4 2022
|
21 |
731,679 |
ELS, VTI, PARR, EQR
|
13F-HR
|
2/14/2023 |
000090514823000250 |
|
Q3 2022
|
25 |
672,022 |
ELS, EQR, VTI, EQC
|
13F-HR
|
11/14/2022 |
000156761922020079 |
|
Q2 2022
|
25 |
745,688 |
ELS, PARR, EQR, VTI
|
13F-HR
|
8/15/2022 |
000156761922016246 |
|
Q1 2022
|
33 |
896,678 |
ELS, PARR, EQR, VTI
|
13F-HR
|
5/16/2022 |
000156761922010984 |
|
Q4 2021
|
34 |
971,180 |
ELS, PARR, EQR, VTI
|
13F-HR
|
2/14/2022 |
000156761922004375 |
|
Q3 2021
|
32 |
1,179,717 |
ELS, CVA, PARR, EQR
|
13F-HR
|
11/15/2021 |
000156761921020447 |
|
Q2 2021
|
35 |
1,141,540 |
ELS, CVA, PARR, EQR
|
13F-HR
|
8/16/2021 |
000156761921015832 |
|
Q1 2021
|
33 |
978,931 |
ELS, PARR, CVA, EQR
|
13F-HR
|
5/17/2021 |
000156761921010506 |
|
Q4 2020
|
24 |
924,707 |
ELS, PARR, CVA, EQR
|
13F-HR
|
2/16/2021 |
000156761921004038 |
|
Q3 2020
|
22 |
714,147 |
ELS, CVA, PARR, EQC
|
13F-HR
|
11/16/2020 |
000156761920019863 |
|
Q2 2020
|
22 |
782,845 |
ELS, CVA, PARR, EQC
|
13F-HR
|
8/14/2020 |
000156761920015473 |
|
Q1 2020
|
24 |
786,537 |
ELS, CVA, AXE, PARR
|
13F-HR
|
5/15/2020 |
000156761920010501 |
|
Q4 2019
|
23 |
1,199,660 |
PARR, ELS, CVA, AXE
|
13F-HR
|
2/14/2020 |
000156761920004014 |
|
Q3 2019
|
20 |
1,188,898 |
PARR, ELS, CVA, AXE
|
13F-HR
|
11/14/2019 |
000156761919021561 |
|
Q2 2019
|
20 |
1,109,950 |
PARR, CVA, ELS, EQR
|
13F-HR
|
8/14/2019 |
000156761919016997 |
|
Q1 2019
|
20 |
1,048,229 |
PARR, CVA, ELS, EQR
|
13F-HR
|
5/15/2019 |
000156761919011197 |
|
Q4 2018
|
21 |
890,022 |
PARR, CVA, ELS, AXE
|
13F-HR
|
2/14/2019 |
000156761919004386 |
|
Q3 2018
|
22 |
1,093,952 |
PARR, CVA, ELS, AXE
|
13F-HR
|
11/14/2018 |
000156761918006273 |
|
Q2 2018
|
21 |
1,017,932 |
PARR, CVA, ELS, AXE
|
13F-HR
|
8/14/2018 |
000156761918001006 |
|
Q1 2018
|
23 |
1,010,447 |
PARR, CVA, AXE, ELS
|
13F-HR
|
5/15/2018 |
000114036118023920 |
|
Q4 2017
|
23 |
1,098,514 |
PARR, CVA, AXE, ELS
|
13F-HR
|
2/14/2018 |
000114036118008275 |
|
Q3 2017
|
22 |
1,126,273 |
PARR, AXE, CVA, ELS
|
13F-HR
|
11/14/2017 |
000114036117042828 |
|
Q2 2017
|
20 |
950,898 |
PARR, CVA, AXE, EXTERRAN CORP
|
13F-HR
|
8/14/2017 |
000114036117032044 |
|
Q1 2017
|
18 |
985,860 |
PARR, CVA, AXE, EXTERRAN CORP
|
13F-HR
|
5/15/2017 |
000114036117020712 |
|
Q4 2016
|
18 |
927,755 |
CVA, PARR, AXE, EQC
|
13F-HR
|
2/15/2017 |
000114036117007537 |